Search for a command to run...
No recent news available for this stock.
Conference call summary is not available for this stock.
Syschem (India) Ltd. is significantly underperforming in key financial metrics compared to its peers in the Pharmaceuticals & Drugs industry. The analysis highlights strong players like Sun Pharmaceutical Industries and Cipla Ltd., while Syschem shows no revenue growth, profitability, or efficiency. Financially, it is a weak choice among the competitors.
Highest revenue growth (YoY: 8.42%) and strong profitability (ROE: 16.13%).
Consistent growth (YoY: 13.28%) with a low PE ratio of 23.73, making it a solid performer.